子宫切除术与侵袭性上皮性卵巢及输卵管癌风险的队列研究
基于UKCTOCS队列中202 506名绝经后女性,随访至2014年底,比较保留单侧或双侧附件的子宫切除术者与子宫完整者的侵袭性上皮性卵巢/输卵管癌发生风险,多因素分析未发现关联(HR 0.98,95%CI 0.85-1.13,P=0.765)。
要点
- 子宫切除保留附件者卵巢/输卵管癌发生率为0.55%(231/41 912)。
- 多因素分析未显示子宫切除术与侵袭性上皮性卵巢/输卵管癌相关(HR 0.98,95%CI 0.85-1.13)。
- 该结果可为临床咨询和风险预测模型提供依据。
核心结论
- 子宫切除术与侵袭性上皮性卵巢和输卵管癌风险改变无关。
研究设计与样本
- 前瞻性队列研究,纳入2001—2005年UKCTOCS招募的202 506名绝经后女性,随访至2014年12月31日。
主要发现
- 子宫切除保留单侧或双侧附件者占20.7%(41 912/202 506)。
- 子宫切除者卵巢/输卵管癌诊断比例0.55%(231/41 912),子宫完整者为0.59%(945/160 594)。
关键数值与推荐
- 多因素分析:子宫切除术与侵袭性上皮性卵巢/输卵管癌的HR为0.98(95%CI 0.85-1.13,P=0.765)。
临床怎么用
- 可用于向接受子宫切除术(保留附件)的女性进行风险咨询,并有助于完善风险预测模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between hysterectomy with conservation of one or both adnexa and ovarian and tubal cancer. DESIGN: Prospective cohort study. SETTING: Thirteen NHS Trusts in England, Wales and Northern Ireland. POPULATION: A total of 202 506 postmenopausal women recruited between 2001 and 2005 to the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) and followed up until 31 December 2014. METHODS: Multiple sources (questionnaires, hospital notes, Hospital Episodes Statistics, national cancer/death registries, ultrasound reports) were used to obtain accurate data on hysterectomy (with conservation of one or both adnexa) and outcomes censored at bilateral oophorectomy, death, ovarian/tubal cancer diagnosis, loss to follow up or 31 December 2014. Cox proportional hazards regression models were used to assess the association. MAIN OUTCOME MEASURES: Invasive epithelial ovarian and tubal cancer (WHO 2014) on independent outcome review. RESULTS: Hysterectomy with conservation of one or both adnexa was reported in 41 912 (20.7%; 41 912/202 506) women. Median follow up was 11.1 years (interquartile range 9.96-12.04), totalling >2.17 million woman-years. Among women who had undergone hysterectomy, 0.55% (231/41 912) were diagnosed with ovarian/tubal cancer, compared with 0.59% (945/160 594) of those with intact uterus. Multivariable analysis showed no evidence of an association between hysterectomy and invasive epithelial ovarian/tubal cancer (hazard ratio 0.98, 95% CI 0.85-1.13, P = 0.765). CONCLUSIONS: This large cohort study provides further independent validation that hysterectomy is not associated with alteration of invasive epithelial ovarian and tubal cancer risk. These data are important both for clinical counselling and for refining risk prediction models. TWEETABLE ABSTRACT: Hysterectomy does not alter risk of invasive epithelial ovarian and tubal cancer.
引用
- Taylor JA, Burnell M, Ryan A, et al. Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS. BJOG. 2021. PMID: 34555263. doi:10.1111/1471-0528.16943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。